Placebo for BOTOX
Phase 3
AbbViePlacebo for BOTOX is one of 2 therapeutic programs targeting Masseter Muscle Prominence. It is currently in Phase 3.
1
Indications
1
Total Trials
0
Active Trials
1
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
1 competitor in Masseter Muscle Prominence
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Placebo for BOTOX. EMBL-EBI & Wellcome Sanger Institute.
- [3]